CA3092935C - Vaccins contre l'hepatite b et utilisations de ces derniers - Google Patents

Vaccins contre l'hepatite b et utilisations de ces derniers

Info

Publication number
CA3092935C
CA3092935C CA3092935A CA3092935A CA3092935C CA 3092935 C CA3092935 C CA 3092935C CA 3092935 A CA3092935 A CA 3092935A CA 3092935 A CA3092935 A CA 3092935A CA 3092935 C CA3092935 C CA 3092935C
Authority
CA
Canada
Prior art keywords
hbv
domain
sequence
polynucleotide
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3092935A
Other languages
English (en)
Other versions
CA3092935A1 (fr
Inventor
Douglas E. Brough
Cheryl G. BOLINGER
Ramya Yarlagadda
Vinodhbabu KURELLA
Prabakaran Ponraj
Simon METENOU
Kuan-Fu Ding
Original Assignee
Precigen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Precigen Inc filed Critical Precigen Inc
Priority claimed from PCT/US2019/020930 external-priority patent/WO2019173463A1/fr
Publication of CA3092935A1 publication Critical patent/CA3092935A1/fr
Application granted granted Critical
Publication of CA3092935C publication Critical patent/CA3092935C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des constructions de vaccin moléculaire du virus de l'hépatite B (VH) spécifiquement modifié. Des constructions de vaccin peuvent également comprendre des systèmes de commutation de gènes spécifiquement modifiés inductibles par ligand pour moduler l'expression de gènes hétérologues, tels que des cytokines, dans des cellules hôtes.
CA3092935A 2018-03-06 2019-03-06 Vaccins contre l'hepatite b et utilisations de ces derniers Active CA3092935C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862639354P 2018-03-06 2018-03-06
US62/639,354 2018-03-06
PCT/US2019/020930 WO2019173463A1 (fr) 2018-03-06 2019-03-06 Vaccins contre l'hépatite b et utilisations de ces derniers

Publications (2)

Publication Number Publication Date
CA3092935A1 CA3092935A1 (fr) 2019-09-12
CA3092935C true CA3092935C (fr) 2026-03-03

Family

ID=

Similar Documents

Publication Publication Date Title
US20260098063A1 (en) Human papillomavirus vaccines and uses of the same
US12234261B2 (en) Hepatitis B vaccines and uses of the same
JP2020527937A (ja) 新規の細胞タグの発現
US20240173396A1 (en) Human Papilloma Virus Vaccines and Uses of the Same for HPV Associated Diseases
CA3092935C (fr) Vaccins contre l'hepatite b et utilisations de ces derniers
RU2850195C1 (ru) Вакцины против вируса папилломы человека и их применение для лечения заболеваний, связанных с hpv
US20240390475A1 (en) Human papillomavirus vaccines and uses of the same
US20240398926A1 (en) Novel adenovirus vaccine therapy for the treatment of recurrent respiratory papillomatosis